ChemicalBook >> CAS DataBase List >>XGZZHZMWIXFATA-VQNNHZPYSA-N
XGZZHZMWIXFATA-VQNNHZPYSA-N
- CAS No.
- 163712-68-3
- Chemical Name:
- XGZZHZMWIXFATA-VQNNHZPYSA-N
- Synonyms
- XGZZHZMWIXFATA-VQNNHZPYSA-N;Controlled Substance(Nalfurafine Impurity 4);2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (Z)- (9CI);(Z)-N-((4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)-3-(furan-3-yl)-N-methylacrylamide
- CBNumber:
- CB83395752
- Molecular Formula:
- C28H32N2O5
- Molecular Weight:
- 476.57
- MDL Number:
- MOL File:
- 163712-68-3.mol
Last updated:2023-05-15 10:43:27
| Product description | Number | Pack Size | Price |
| 2Z-Nalfurafine | TRC-N255610-5MG | 5mg | $275 |
| 2Z-Nalfurafine | TRC-N255610-50MG | 50mg | $2149 |
XGZZHZMWIXFATA-VQNNHZPYSA-N Chemical Properties,Uses,Production
Uses
2Z-Nalfurafine-d3 is the labeled analogue of 2Z-Nalfurafine (N255610), a geometric isomer of Nalfurafine (N255600), a on-narcotic opioid drug for intractable itch caused by hemodialysis. It showed significant opioid κ-agonist activity and induced neither aversion nor preference in rats on the CPP (Conditioned Place Preference) test. Nalfurafine is a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients.
XGZZHZMWIXFATA-VQNNHZPYSA-N Preparation Products And Raw materials
Raw materials
Preparation Products
XGZZHZMWIXFATA-VQNNHZPYSA-N Suppliers
Global( 13)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| QUALITY CONTROL SOLUTIONS LTD. | +86-0755-66853366 +8613670046396 | export03@qcsrm.com | China | 24342 | 58 |
| Quality Control Solutions Ltd. | 0755-66853366 13670046396 | orders@qcsrm.com | China | 18190 | 56 |
| TOSUN PHARM | 020-66392521-118 18922260391 | 3004261881@qq.com | China | 7978 | 58 |
| Hubei Xinyang Medical Technology Co., Ltd | 15347293736 | 2853117764@yongstandards.com | China | 9999 | 58 |
| Energy Chemical | 021-58432009 400-005-6266 | marketing@energy-chemical.com | China | 44918 | 58 |
| Guangzhou Austine Biotechnology Co., LTD | 15918640830 13268843209 | 1947181658@qq.com | China | 9029 | 58 |
| HX Pharmaceutical technology co., LTD | 15671363360 | 494267389@qq.com | China | 3611 | 58 |
| Shanghai Easy CDMO Co.,Ltd | 13564957716 | Info@easycdmo.com | China | 9999 | 58 |
| Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd | 18162595016; 18162595016 | 3287908757@qq.com | China | 9119 | 58 |
| Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 | 2208093734@qq.com | China | 8204 | 58 |
XGZZHZMWIXFATA-VQNNHZPYSA-N
2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (Z)- (9CI)
(Z)-N-((4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)-3-(furan-3-yl)-N-methylacrylamide
Controlled Substance(Nalfurafine Impurity 4)
163712-68-3




